Bloomberg Business, October 23, 2020. We, with other, scientists and advocates criticize weak Covid-19 vaccine standards at FDA Advisory Panel Meeting.
Read More »Author: Caroline Bradford
FDA Panel To Lay Regulatory Groundwork For COVID-19 Vaccine
NPR, October 22, 2020. Dr. Diana Zuckerman spoke about making sure vaccines aren’t rushed through too quickly to be safe at the FDA advisory meeting on Covid-19 vaccine approval.
Read More »Study finds removing breast implants improved symptoms
AzFamily.com, October 1, 2020. The FDA is finally encouraging better information about the risks of cancer, breast implant illness, and other health problems for women considering breast implants. But we agree with patients that the agency could do so much more.
Read More »FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects
Cure, September 29, 2020. Makers of breast implants should include a black box warning about cancer and other serious risks, along with a patient decision checklist for patients to sign, according to final guidance issued by the FDA.
Read More »Open Letter to Stephen M. Hahn, M.D., Commissioner of the Food and Drug Administration: #ProtectTheFDA
In September 2020, medical and public health experts wrote to the FDA
Commissioner to express concern about political influence on FDA’s COVID-19 vaccine
decision-making, saying it could potentially compromise scientific integrity and public trust. The
open letter called on Commissioner Hahn to ensure vaccine approvals remain independent,
transparent, data-driven, and free from partisan pressure, urging actions like consulting with
other scientific bodies before issuing emergency authorizations.